Hopefully you'll get some detailed answers with your deeply knowledge of the business. Delcath promissed some milestones till the end of 2016, but a little delay should be no problem.
Third day in a row with a higher low is not too bad, but a little green at the end of the day would even be better...some day.
The potential is here..no question imo, but patience is really hard when you see biotechs exploding all around :-(
News 
Market Data 
Discover 
